Quantum BioPharma
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 University Ave Ste 1003, Toronto, Ont...Phone Number
(833) 571-1811Website
www.quantumbiopharma.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Quantum BioPharma
Quantum BioPharma Ltd. is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its mission is to develop novel solutions for brain and inflammatory disorders. It aims to be a world class innovation driven biopharmaceutical company to improve the quality of life of patients.Explore more
Quantum BioPharma Org Chart
AC
Vice President, Clinical and Scientific Affai...
KC
Vice President, Quality Systems
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quantum BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Quantum BioPharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Quantum BioPharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Quantum BioPharma
Check out if Quantum BioPharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Quantum BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Quantum BioPharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Quantum BioPharma recently announced quarterly report
Product Launch: Get notified when Quantum BioPharma launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Quantum BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Quantum BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Quantum BioPharma.
Quantum BioPharma financials insights
Gather financial insights about Quantum BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Share Placement
$5M
Quantum BioPharma News & Media
NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
AUSTIN, Texas, June 26, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis,” featuring Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM).Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
Disseminated on behalf of Quantum BioPharma, may include paid advertisements.
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quantum BioPharma
Sign Up For FreeTo access detailed company insights
Quantum BioPharma Ltd. is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its mission is to develop novel solutions for b... Read More
